A consensus statement from the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) included key areas for research to address challenges in the management of gout in patients with chronic kidney disease.
Experts discuss emerging safety data on administration of COVID-19 mRNA vaccines during pregnancy.
Do gastroprotective and promotility agents prevent incident interstitial lung disease in patients with systemic sclerosis?
Researchers conducted a study to determine whether SARS-CoV-2 viral RNA detected in the bloodstreams of patients with COVID-19 is reflective of viremia or related to host immune responses and outcomes.
The use of patient-reported outcome measures (PROMs) to complement CROs may yield important information for assessing disease severity and guiding treatment of psoriasis.
In patients with RA, engaging in risk-stratification practices can mitigate the potential for fatalities of reactivated HBV, with pretherapy screening the most effective tool currently available.
The trajectory and characteristics of glucocorticoid tapering and discontinuation in patients with RA who initiated GC with concurrent csDMARDs is delineated.
The association between ACPA and cit-H3 protein found in NET remnants of induced sputum samples of patients at-risk for RA is investigated.
A potential link between the introduction of bDMARDS and rates of total hip and knee arthroplasty in patients with RA vs OA is investigated.
The objective of this study was to improve treatment of patients with RA by developing and validating a tool to help clinicians identify and evaluate adherence to methotrexate.
Please login or register first to view this content.
